Skip to main content
Premium Trial:

Request an Annual Quote

BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership

NEW YORK — BGI Americas said on Tuesday that it has signed an agreement to market its PCR-based SARS-CoV-2 detection kit with Advaite's RapCov COVID-19 immunoassay to hospitals and healthcare facilities.

BGI America's Real-Time Fluorescent RT-PCR Kit is designed to detect SARS-CoV-2 nucleic acid in throat swabs and bronchoalveolar lavage fluid in approximately three hours. It received Emergency Use Authorization from the US Food and Drug Administration in early 2020.

The RapCov Rapid COVID-19 Test is a lateral flow assay designed to detect IgG against SARS-CoV-2 using a fingerstick blood sample in point-of-care settings, providing results in 15 minutes. Malvern, Pennsylvania-based Advaite received FDA EUA for the test in January of this year.

San Jose-based BGI Americas said that offering the assays together will provide customers with both central laboratory and point-of-care CLIA-waived testing options for SARS-CoV-2 testing.

Financial and other terms of the partnership were not disclosed.

BGI Americas also said that it has launched a website through which it solicits licensing, original equipment manufacturer, or distribution agreements with other diagnostic companies for their products.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.